EBS Emergent BioSolutions Inc.

NEUTRAL Impact: 3/10 DEFA14A
Horizon immediate Filed Apr 16, 2026 Processed 1mo ago SEC 0001193125-26-158134
Proxy solicitation materials
Latest settled — T+20d ⚠ clustered
EBS ▼ -3.36% at T+20d
NEUTRAL call ✗ call lost -3.36% · α vs SPY -9.18% · entry $8.62 → $8.33
Next anchor: T+60d in 7w
Last close $8.45 (close May 22) · -1.97% from $8.62 entry
Entry anchored
Apr 15, 03:59 PM ET
via Databento tick
T+1d
+2.20%
call +2.20% · α +0.99%
$8.81
settled 5w ago
T+5d
-6.15%
call -6.15% · α -7.13%
$8.09
settled 4w ago
T+20d
-3.36%
call -3.36% · α -9.18%
$8.33
settled 10d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Emergent BioSolutions Inc. filed its definitive proxy statement for the 2026 annual shareholder meeting, scheduled for April 29, 2026. The filing serves as a reminder for shareholders to vote on matters including director elections and executive compensation, with voting accessible via proxy.

Actionable Insight

Investors should review proxy materials for details on board nominees, executive pay, and any shareholder proposals ahead of the vote. No material changes or surprises are indicated in this filing.

Key Facts

  • Filing is a Definitive Proxy Statement (DEFA14A) for the 2026 annual meeting.
  • Annual meeting date is April 29, 2026, at 9:00 AM Eastern Time.
  • Shareholders of record as of March 6, 2026, are eligible to vote.
  • Voting can be completed by proxy, with instructions sent via email through E*TRADE.

Financial Impact

No direct financial impact; routine corporate governance filing.

governanceshareholder engagement

Risk Factors

  • Low engagement from shareholders could affect voting outcomes on key proposals.
  • Potential for activist shareholder activity if dissatisfaction with management arises.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-158134
Document: 0001193125-26-158134-index-headers.html0001193125-26-158134
Document: 0001193125-26-158134-index.html0001193125-26-158134
Document: 0001193125-26-158134.txt0001193125-26-158134
13 reports for EBS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for EBS — sortable, filterable
Type Now
Apr 30, 2026
23d ago
Press Release
MIXED ★ 6/10
$8.47 $9.13▲ +7.79%▲ +5.45%$8.45 (−0.24%)
Apr 30, 2026
24d ago
Insider Cluster
NEUTRAL ★ 2/10
$8.23 $9.10▲ +10.57%▲ +8.84%$8.45 (+2.67%)
Apr 29, 2026
24d ago
Press Release
BULLISH ★ 4/10
awaiting T+5
Apr 29, 2026
24d ago
Press Release
NEUTRAL ★ 1/10
awaiting T+5
Apr 28, 2026
25d ago
DEFA14A
NEUTRAL ★ 2/10
$8.23 $8.54▲ +3.77%▲ +2.07%$8.45 (+2.67%)
Apr 28, 2026
25d ago
Press Release
NEUTRAL ★ 4/10
$8.23 $8.54▲ +3.77%▲ +2.07%$8.45 (+2.67%)
Apr 27, 2026
26d ago
DEFA14A
NEUTRAL ★ 2/10
$8.23 $8.54▲ +3.77%▲ +2.07%$8.45 (+2.67%)
Apr 16, 2026
5w ago
Press Release
NEUTRAL ★ 3/10
$8.81 $8.03▼ −8.85%▼ −9.41%$8.45 (−4.09%)
Apr 16, 2026
5w ago
Press Release
BEARISH ★ 7/10
$8.81 $8.03▲ +8.85%▲ +9.41%$8.45 (+4.09%)
Apr 16, 2026
5w ago
DEFA14A
NEUTRAL ★ 3/10
$8.62 $8.09▼ −6.15%▼ −7.13%$8.45 (−1.97%)
Showing 10 of 13

US Market Status

Market Closed — Opens Tue (34h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access